Membranoproliferative glomerulonephritis: Difference between revisions
Olufunmilola (talk | contribs) |
Olufunmilola (talk | contribs) |
||
| Line 25: | Line 25: | ||
== [[Membranoproliferative glomerulonephritis classification|Classification]] == | == [[Membranoproliferative glomerulonephritis classification|Classification]] == | ||
Classification of MPGN based on immunofluorescence microscopy is a result of all advances in the understanding of the pathogenesis of the disease. Based on this advanced techniques, there are three types of MPGN <ref name="pmid21839367">{{cite journal| author=Sethi S, Fervenza FC| title=Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification. | journal=Semin Nephrol | year= 2011 | volume= 31 | issue= 4 | pages= 341-8 | pmid=21839367 | doi=10.1016/j.semnephrol.2011.06.005 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21839367 }} </ref>; | |||
*Immune-complex-mediated MPGN (Type I) | |||
*Complement-mediated MPGN (Type II) | |||
*Non-Ig/complement-mediated MPGN (Type III) | |||
== [[Membranoproliferative glomerulonephritis pathophysiology|Pathophysiology]] == | == [[Membranoproliferative glomerulonephritis pathophysiology|Pathophysiology]] == | ||
Revision as of 20:13, 17 November 2016
| Membranoproliferative glomerulonephritis | |
| ICD-10 | N00-N08 with .2 suffix |
|---|---|
| ICD-9 | 581.2, 582.2, 583.2 |
| MeSH | D015432 |
|
Membranoproliferative glomerulonephritis Microchapters |
|
Differentiating Membranoproliferative glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Membranoproliferative glomerulonephritis On the Web |
|
American Roentgen Ray Society Images of Membranoproliferative glomerulonephritis |
|
Directions to Hospitals Treating Membranoproliferative glomerulonephritis |
|
Risk calculators and risk factors for Membranoproliferative glomerulonephritis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ali Poyan Mehr, M.D. [2]; Associate Editor-In-Chief: Olufunmilola Olubukola M.D.[3]Cafer Zorkun, M.D., Ph.D. [4]
Overview
Membranoproliferative Glomerulonephritis (MPGN) is a relatively uncommon inflammatory glomerulopathy that can cause chronic nephritis. Based on the histological pattern of glomerular injury it has been described as a chronic kidney disease found mostly in children and young adults. Like many forms of glomerulopathies, membranoproliferative glomerulonephritis (glomerulopathy) has been a diagnosis of tissue pathology rather the diagnosis of a specific disease entity. Therefore, the term membranoploriferative glomerulonephritis (MPGN) relates to a pattern of glomerular injury characterized by mesangial proliferation and expansion, lobularization of the glomerular tufts and double contours which can be caused by many disease states [1]. Glomerular injury occurs due to deposition of immune complexes on the glomerular mesangium or on the glomerular basement membrane. MPGN has been categorized into 3 types based on the histological pattern of glomerular damage. Clinically, MPGN often present with hematuria, varying degrees of proteinuria, with or without Glomerular filtration rate impairment depending on the severity of glomerular injury, and the underlying etiology.
Historical Perspective
Classification
Classification of MPGN based on immunofluorescence microscopy is a result of all advances in the understanding of the pathogenesis of the disease. Based on this advanced techniques, there are three types of MPGN [2];
- Immune-complex-mediated MPGN (Type I)
- Complement-mediated MPGN (Type II)
- Non-Ig/complement-mediated MPGN (Type III)
Pathophysiology
Causes
Differentiating Membranoproliferative glomerulonephritis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
et:Membranoproliferatiivne glomerulonefriit
- ↑ Lionaki S, Gakiopoulou H, Boletis JN (2016). "Understanding the complement-mediated glomerular diseases: focus on membranoproliferative glomerulonephritis and C3 glomerulopathies". APMIS. 124 (9): 725–35. doi:10.1111/apm.12566. PMID 27356907.
- ↑ Sethi S, Fervenza FC (2011). "Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification". Semin Nephrol. 31 (4): 341–8. doi:10.1016/j.semnephrol.2011.06.005. PMID 21839367.